[1]
Yasser, S. and Hesham, M. 2022. Empagliflozin-Induced Acute Pancreatitis and Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus. American Journal of Chemistry and Pharmacy. 1, 2 (Oct. 2022), 1–4. DOI:https://doi.org/10.54536/ajcp.v1i2.747.